Online citations, reference lists, and bibliographies.
← Back to Search

Diagnosis And Treatment Of Malignant Pleural Effusion

S. Call, D. Sanchez, R. Rami‐Porta
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant pleural effusion (MPE) is a common clinical problem in patients with neoplastic disease. The optimal palliative management for patients with symptomatic MPE is not well understood. There is a variety of possible treatments: thoracentesis or repeat thoracentesis; instillation of irritating agents into the pleural cavity by the thoracostomy tube or under thoracoscopic vision; alternatives to the pleurodesis such as chronic indwelling pleural catheter and pleuroperitoneal shunt for those cases with trapped lung. The treatment choice depends on the clinician’s specialty and expertise, the patient’s performance status and the hospitalization status. This chapter presents a comprehensive review of the current methods for diagnosing and managing patients with MPE.
This paper references
10.1002/DC.10227
Diagnostic value of eosinophils in pleural effusion: A prospective study of 26 cases
Smita Mary Matthai (2003)
10.1159/000196384
Intrapleural Corynebacterium parvum for recurrent malignant pleural effusions.
V. Foresti (1995)
10.1016/S0140-6736(03)13079-6
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial
N. Maskell (2003)
10.1378/CHEST.128.3.1431
Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
S. Kolschmann (2005)
10.1378/chest.10-1259
Pleuroscopy for diagnosis and therapy for pleural effusions.
Gaetane Michaud (2010)
10.1378/CHEST.129.6.1549
The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions.
B. Chakrabarti (2006)
10.1183/09031936.97.10081907
Pleural diseases related to metastatic malignancies.
S. Sahn (1997)
10.1378/CHEST.125.2.489
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
B. Duysinx (2004)
10.1007/BF02303632
Parietal pleurectomy for malignant pleural effusion
W. Fry (2006)
10.1378/CHEST.110.6.1387
Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.
J. Viallat (1996)
10.1016/j.lungcan.2008.02.017
Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
H. Yildirim (2008)
10.1378/CHEST.107.5.1454
Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.
D. Waller (1995)
10.1183/09031936.01.00225601
Management of malignant pleural effusions.
V. Antony (2001)
10.7326/0003-4819-108-3-345
Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.
S. Sahn (1988)
10.1183/09031936.97.10071648
Pleurodesis: state of the art.
F. Rodríguez-Panadero (1997)
10.4065/83.2.235
Recent advances in the diagnosis and management of malignant pleural effusions.
J. Heffner (2008)
10.1002/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M
A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions
J. Putnam (1999)
10.1016/j.radonc.2008.06.009
A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).
M. Suzuki (2008)
10.1158/1078-0432.CCR-09-3324
Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid
N. Dickgreber (2010)
10.5555/URI:PII:0093775492902608
Bleomycin and tetracycline in malignant pleural effusions: a review.
M. Moffett (1992)
10.1136/thx.2010.136994
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
M. Roberts (2010)
10.1097/JTO.0b013e318070ccaf
State of the Art: Pleuroscopy
P. Lee (2007)
10.1016/S0272-5231(05)70082-4
Malignancy metastatic to the pleura.
S. Sahn (1998)
Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
M. J. Gaspar (2008)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1378/CHEST.126.6.1757
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
J. M. Porcel (2004)
10.1136/thx.2006.068114
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma
J. Creaney (2007)
10.1055/s-2008-1039314
The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
A. Orki (2009)
10.1007/s00408-008-9085-7
Differential Diagnosis of Tuberculous and Malignant Pleural Effusions: What is the Role of Adenosine Deaminase?
B. Zaric (2008)
10.1136/thx.2008.100545
Thoracic ultrasound in the diagnosis of malignant pleural effusion
N. R. Qureshi (2008)
10.1111/j.1440-1843.2006.00792.x
Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy
R. Agarwal (2006)
Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial.
J. Kużdżał (2003)
10.1097/01.rli.0000091654.32872.57
The Clinical Impact of Camera-Based Positron Emission Tomography Imaging in Patients With Recurrent Colorectal Cancer
E. Miller (2004)
10.1016/J.EJCTS.2005.12.025
The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
C. Tan (2006)
10.1016/S0009-9260(81)80042-6
Ultrasound of the pleura: an assessment of its clinical value.
D. Lipscomb (1981)
10.1002/1097-0142(197503)35:3<734::AID-CNCR2820350328>3.0.CO;2-N
Indications for pleurectomy in malignant effusion
N. Martini (1975)
Survival of patients with malignancy-associated effusions.
van de Molengraft Fj (1989)
10.1378/chest.09-0884
Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.
M. Metintas (2010)
10.1093/OXFORDJOURNALS.ANNONC.A057908
Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone).
G. Groth (1991)
10.1016/S1010-7940(96)01008-1
Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
O. Soysal (1997)
10.1002/(SICI)1097-0142(19960815)78:4<736::AID-CNCR7>3.0.CO;2-C
Diagnostic value of CA 72‐4, carcinoembryonic antigen, CA 15‐3, and CA 19‐9 assay in pleural fluid: A study of 207 patients
V. Villena (1996)
10.2214/AJR.148.4.681
Detection of pleural effusions on supine chest radiographs.
J. A. Ruskin (1987)
10.1164/ajrccm.162.5.ats8-00
[Management of malignant pleural effusions].
R. Loddenkemper (2005)
10.1097/JTO.0b013e3181c07ddc
Phase I Trial of Intrapleural Docetaxel Administered Through an Implantable Catheter in Subjects with a Malignant Pleural Effusion
D. Jones (2010)
10.1007/s00520-005-0001-x
Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions
J. M. Porcel (2005)
10.1111/j.1440-1843.2006.00790.x
Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non‐small cell lung cancer
A. Ishida (2006)
10.1007/s11307-009-0203-6
Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma
S. Lee (2009)
10.1016/j.ejcts.2010.09.005
Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
T. Mohsen (2011)
10.1016/J.CRAD.2006.05.002
Image-guided pleural biopsy: diagnostic yield and complications.
R. Benamore (2006)
10.1016/j.ejcts.2008.07.050
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.
J. Sørensen (2008)
10.1183/09031936.05.00027505
Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results
M. G. Chrysanthidis (2005)
10.1097/COC.0b013e3181aacbbf
Diagnosis and Treatment of Malignant Pleural Effusion: A Systematic Literature Review and New Approaches
G. Lombardi (2010)
10.1016/S1076-6332(05)80373-3
Pleural fluid volume estimation: a chest radiograph prediction rule.
C. Blackmore (1996)
10.1097/MCP.0b013e3283474015
Management of malignant pleural effusions
F. Rodríguez-Panadero (2011)
PET for the evaluation of pleural thickening observed on CT.
H. Kramer (2004)
10.1016/S0012-3692(15)33487-5
Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin.
A. Cantó (1983)
10.1002/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO;2-U
The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients
W. W. Johnston (1985)
10.2214/AJR.175.1.1750245
FDG PET of pleural effusions in patients with non-small cell lung cancer.
J. Erasmus (2000)
10.1378/CHEST.123.2.436
Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound.
A. Diacon (2003)
10.1148/RADIOL.2313030785
Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
G. Schaffler (2004)
10.1097/JTO.0b013e3181cbf465
Role of Integrated 18-Fluorodeoxyglucose Position Emission Tomography-Computed Tomography in Patients Surveillance after Multimodality Therapy of Malignant Pleural Mesothelioma
C. Tan (2010)
10.1183/09031936.04.00137403
Efficacious pleurodesis with OK‐432 and doxorubicin against malignant pleural effusions
K. Kishi (2004)
10.1111/j.1440-1843.2009.01663.x
Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions
J. A. Neto (2010)
10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y
Diagnostic utility of CYFRA 21‐1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions
J. Ferrer (1999)
10.1002/14651858.CD002916.pub3
WITHDRAWN: Pleurodesis for malignant pleural effusions.
P. Shaw (2013)
10.1378/CHEST.122.2.581
Iodopovidone pleurodesis for recurrent pleural effusions.
Carlos A Olivares-Torres (2002)
10.1378/CHEST.129.6.1398
Closed pleural biopsy: not dead yet!
M. Baumann (2006)
10.1097/JTO.0b013e3182208e3f
Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group
D. Rice (2011)
10.1136/thx.48.8.790
Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.
S. Koldsland (1993)
Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
K. Kasahara (2006)
10.1159/000247335
Narrow Band Imaging Applied to Pleuroscopy for the Assessment of Vascular Patterns of the Pleura
A. Ishida (2009)
10.1200/JCO.20005.14.589
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
J. Van Meerbeeck (2005)
10.1016/S1051-0443(07)61826-0
Treatment of malignant pleural effusions with tunneled long-term drainage catheters.
J. Pollak (2001)
10.1016/J.EJCTS.2006.03.016
Needle tract implantation clearly visualized by computed tomography following needle biopsy of malignant mesothelioma.
K. Suzuki (2006)
10.1183/09031936.06.00097505
The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis
K. Psathakis (2006)
10.1378/CHEST.107.6.1707
Talc slurry pleurodesis. Pleural fluid and histologic analysis.
L. Kennedy (1995)
10.1200/JCO.2004.09.164
Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
S. Sartori (2004)
Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
J. Kelly-García (1997)
10.2967/jnumed.107.042333
Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
R. Francis (2007)
10.1016/J.LUNGCAN.2006.04.016
Malignant pleural effusion, current and evolving approaches for its diagnosis and management.
S. Neragi-Miandoab (2006)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions.
C. Ohm (2003)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1016/j.rmed.2008.07.008
Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
B. Duysinx (2008)
10.1016/S1470-2045(08)70239-0
The ideal pleurodesis agent: still searching after all these years.
H. G. Colt (2008)
10.1016/S0022-5223(19)33712-2
Talc pleurodesis. Experience with 360 patients.
D. Weissberg (1993)
10.1097/00128594-199810000-00016
Closed Needle Biopsy of the Pleura is a Valuable Diagnostic Procedure
M. Baumann (1998)
10.1245/s10434-010-1447-8
Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting?
R. Terra (2010)
10.1097/01.mcp.0000166587.24127.91
Alternative widely available, inexpensive agents for pleurodesis
O. Dikensoy (2005)
10.1378/CHEST.128.2.684
Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.
M. S. Paschoalini (2005)
10.3949/CCJM.61.2.127
Pleural changes in malignant pleural effusions: appearance on computed tomography.
P. O'donovan (1994)
10.1200/JCO.2010.28.15_SUPPL.9031
Comparison of in-dwelling catheters and talc pleurodesis in the management of malignant pleural effusions.
T. L. Demmy (2010)
10.1148/RADIOL.2312021185
Clinical applications of PET in oncology.
E. Rohren (2004)
Corynebacterium parvum in malignant pleural effusion. A randomized prospective study.
G. Hillerdal (1986)
10.1056/NEJM195501202520301
Pleural effusion; a statistical study of 436 patients.
E. C. Leuallen (1955)
10.1016/j.ejca.2010.02.002
A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
Xianhuo Wang (2010)
10.1007/s00408-011-9283-6
Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions
S. Bielsa (2011)
10.1016/0002-9343(77)90154-1
Carcinomatous involvement of the pleura: an analysis of 96 patients.
B. Chernow (1977)
10.1378/CHEST.111.6.1597
Recombinant interferon alpha-2b in the management of malignant pleural effusions.
H. Wilkins (1997)
10.1183/09031936.00146808
Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis
A. Montes-Worboys (2009)
10.1136/thx.2010.136978
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
C. Hooper (2010)
10.1002/1097-0142(197803)41:3<1188::AID-CNCR2820410357>3.0.CO;2-O
Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial
T. C. Bayly (1978)
10.1111/j.1440-1843.2007.01144.x
Prospective evaluation of flex‐rigid pleuroscopy for indeterminate pleural effusion: Accuracy, safety and outcome
P. Lee (2007)
10.1111/j.1440-1843.2010.01890.x
Translational advances in pleural malignancies
Georgios T. Stathopoulos (2011)
10.1001/JAMA.1976.03270200021022
Pleural effusion. A diagnostic dilemma.
D. D. Storey (1976)
10.1016/S0003-4975(99)01482-4
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.
J. Putnam (2000)
10.1016/j.rmed.2008.01.022
Emerging paradigms in the management of malignant pleural effusions.
G. Khaleeq (2008)
10.1053/CRAD.2000.0573
Thoracic computed tomography in patients with suspected malignant pleural effusions.
Z. Traill (2001)
10.1378/CHEST.105.6.1743
Clinical efficacy of doxycycline for pleurodesis.
J. Heffner (1994)
10.1378/CHEST.102.5.1455
A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis.
J. Joseph (1992)
10.1093/ANNONC/2.SUPPL_2.213
Report of the first workshop on prognostic factors in large-cell lymphomas.
B. Coiffier (1991)
10.1016/J.ATHORACSUR.2006.06.040
Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis.
T. Kuźniar (2006)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1111/j.1440-1843.2010.01768.x
Thoracic ultrasound prior to medical thoracoscopy improves pleural access and predicts fibrous septation
A. Medford (2010)
10.7326/0003-4819-120-1-199401010-00010
Chemical Pleurodesis for Malignant Pleural Effusions
P. Walker-Renard (1994)
10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
A. Kraft (1999)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
10.1186/1472-684X-3-4
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
N. Barbetakis (2004)
10.1016/J.ATHORACSUR.2005.01.028
Prognostic significance of carcinoembryonic antigen level in pleural lavage fluid for patients with lung adenocarcinoma.
M. Tomita (2005)
10.1378/CHEST.122.6.1918
Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
N. Gupta (2002)
10.1016/S0025-6196(12)60212-2
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
10.1136/thorax.55.12.981
Management of malignant pleural effusions
G. Antunes (2000)
10.1164/AJRCCM/139.3.663
Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis.
F. Rodríguez-Panadero (1989)



Semantic Scholar Logo Some data provided by SemanticScholar